Thursday, February 7, 2019

Cipla gets final approval for generic version of Adcirca

Cipla gets final approval for generic version of Adcirca The city-based firm in a statement said it has received final approval for its ANDA for Tadalafil tablets 20 mg from the United States Food and Drug Administration (USFDA).

from Moneycontrol Business News http://bit.ly/2TBljsh

No comments:

Post a Comment

KPI Green Energy Q4 cons PAT jumps 46% YoY to Rs 155 cr; revenue up 40%

KPI Green Energy Q4 Results: KPI Green Energy announced strong financial results for the fourth quarter of FY26. Net profit surged by 46% t...